Maze Therapeutics (MAZE) Return on Sales (2024 - 2026)

Maze Therapeutics has disclosed Return on Sales across 3 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.06% (changed N/A YoY), and the FY2024 annual result was 0.03%, changed N/A from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at Maze Therapeutics, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q2 2024 to a low of 0.1% in Q3 2024.
• The 3-year median for Return on Sales is 0.01% (2024), against an average of 0.01%.
• Peak annual rise in Return on Sales reached 11 bps in 2025, while the deepest fall reached 0 bps in 2025.
• Maze Therapeutics' Return on Sales stood at 0.0% in 2024, then surged by 326 bps to 0.01% in 2025, then sank by 246 bps to 0.01% in 2026.
• The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.